Flowserve Corporation posted Q4 2025 adjusted EPS of $1.11, including a $1.34 one-time asbestos-related item, on $1.2B revenue, missing by $60M. Learn more on FLS stock here.
Fulcrum Therapeutics, Inc. ( FULC) Q4 2025 Earnings Call February 24, 2026 8:00 AM EST Good morning, and welcome to the Fulcrum Therapeutics conference call to discuss 12-week data from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results